Free Trial

NeuroSense Therapeutics (NRSN) Competitors

NeuroSense Therapeutics logo
$1.13 +0.04 (+3.67%)
Closing price 04:00 PM Eastern
Extended Trading
$1.11 -0.02 (-1.77%)
As of 06:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NRSN vs. RPTX, PDSB, SPRO, OPTN, DYAI, XLO, TNXP, IVVD, ACHL, and ICCC

Should you be buying NeuroSense Therapeutics stock or one of its competitors? The main competitors of NeuroSense Therapeutics include Repare Therapeutics (RPTX), PDS Biotechnology (PDSB), Spero Therapeutics (SPRO), OptiNose (OPTN), Dyadic International (DYAI), Xilio Therapeutics (XLO), Tonix Pharmaceuticals (TNXP), Invivyd (IVVD), Achilles Therapeutics (ACHL), and ImmuCell (ICCC). These companies are all part of the "pharmaceutical products" industry.

NeuroSense Therapeutics vs.

NeuroSense Therapeutics (NASDAQ:NRSN) and Repare Therapeutics (NASDAQ:RPTX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, community ranking, risk, media sentiment and profitability.

NeuroSense Therapeutics has a beta of 1.3, suggesting that its stock price is 30% more volatile than the S&P 500. Comparatively, Repare Therapeutics has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500.

NeuroSense Therapeutics has higher earnings, but lower revenue than Repare Therapeutics. NeuroSense Therapeutics is trading at a lower price-to-earnings ratio than Repare Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NeuroSense TherapeuticsN/AN/A-$11.28M-$0.64-1.77
Repare Therapeutics$51.13M1.03-$93.80M-$2.00-0.62

NeuroSense Therapeutics has a net margin of 0.00% compared to Repare Therapeutics' net margin of -99.76%. NeuroSense Therapeutics' return on equity of 0.00% beat Repare Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
NeuroSense TherapeuticsN/A N/A -590.79%
Repare Therapeutics -99.76%-40.87%-35.07%

1.0% of NeuroSense Therapeutics shares are held by institutional investors. Comparatively, 85.1% of Repare Therapeutics shares are held by institutional investors. 27.4% of NeuroSense Therapeutics shares are held by insiders. Comparatively, 21.6% of Repare Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Repare Therapeutics received 40 more outperform votes than NeuroSense Therapeutics when rated by MarketBeat users. However, 66.67% of users gave NeuroSense Therapeutics an outperform vote while only 63.64% of users gave Repare Therapeutics an outperform vote.

CompanyUnderperformOutperform
NeuroSense TherapeuticsOutperform Votes
2
66.67%
Underperform Votes
1
33.33%
Repare TherapeuticsOutperform Votes
42
63.64%
Underperform Votes
24
36.36%

Repare Therapeutics has a consensus target price of $7.00, indicating a potential upside of 464.52%. Given Repare Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Repare Therapeutics is more favorable than NeuroSense Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NeuroSense Therapeutics
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Repare Therapeutics
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Repare Therapeutics had 1 more articles in the media than NeuroSense Therapeutics. MarketBeat recorded 1 mentions for Repare Therapeutics and 0 mentions for NeuroSense Therapeutics. Repare Therapeutics' average media sentiment score of 0.32 beat NeuroSense Therapeutics' score of 0.00 indicating that Repare Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
NeuroSense Therapeutics Neutral
Repare Therapeutics Neutral

Summary

Repare Therapeutics beats NeuroSense Therapeutics on 10 of the 17 factors compared between the two stocks.

Get NeuroSense Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NRSN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NRSN vs. The Competition

MetricNeuroSense TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$15.45M$6.58B$5.40B$9.13B
Dividend YieldN/A2.96%5.37%4.00%
P/E Ratio-1.779.9688.9717.53
Price / SalesN/A335.131,285.7980.48
Price / CashN/A22.6336.6032.90
Price / Book-8.075.084.964.69
Net Income-$11.28M$154.90M$117.96M$224.57M
7 Day Performance9.71%2.57%2.58%3.33%
1 Month Performance-16.91%1.49%3.53%5.33%
1 Year Performance17.71%5.46%27.05%22.98%

NeuroSense Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NRSN
NeuroSense Therapeutics
0.711 of 5 stars
$1.13
+3.7%
N/A+13.5%$15.45MN/A-1.7710High Trading Volume
RPTX
Repare Therapeutics
2.8106 of 5 stars
$1.31
-5.1%
$7.00
+434.4%
-79.2%$55.69M$66.52M-0.66180News Coverage
Gap Up
PDSB
PDS Biotechnology
1.6813 of 5 stars
$1.42
+0.7%
$11.67
+721.6%
-67.8%$53.12MN/A-1.2220News Coverage
SPRO
Spero Therapeutics
4.6567 of 5 stars
$0.95
-3.2%
$5.00
+426.9%
-34.5%$51.74M$89.87M13.56150
OPTN
OptiNose
4.3966 of 5 stars
$5.02
-5.3%
$26.00
+417.9%
-68.7%$50.50M$75.67M-17.93190
DYAI
Dyadic International
3.1846 of 5 stars
$1.65
flat
$6.00
+263.6%
-3.8%$48.82M$3.36M-7.177Positive News
Gap Down
XLO
Xilio Therapeutics
3.2382 of 5 stars
$1.10
flat
$4.00
+263.6%
+67.9%$48.35M$4.62M-0.6470News Coverage
Positive News
TNXP
Tonix Pharmaceuticals
3.1459 of 5 stars
$0.26
-8.0%
$53.50
+20,765.8%
-97.4%$47.92M$11.29M0.0050
IVVD
Invivyd
3.0097 of 5 stars
$0.40
-11.7%
$7.89
+1,875.8%
-91.4%$47.75M$11.56M-0.20100Short Interest ↑
Negative News
ACHL
Achilles Therapeutics
2.711 of 5 stars
$1.16
-2.1%
$4.00
+244.8%
+38.6%$47.68MN/A-0.70250Positive News
ICCC
ImmuCell
0.1056 of 5 stars
$5.33
+2.7%
N/A+3.7%$47.50M$23.84M-10.6670

Related Companies and Tools


This page (NASDAQ:NRSN) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners